155 related articles for article (PubMed ID: 18555982)
1. Comparison of oxime reactivation and aging of nerve agent-inhibited monkey and human acetylcholinesterases.
Luo C; Tong M; Maxwell DM; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):261-6. PubMed ID: 18555982
[TBL] [Abstract][Full Text] [Related]
2. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes.
Luo C; Tong M; Chilukuri N; Brecht K; Maxwell DM; Saxena A
Biochemistry; 2007 Oct; 46(42):11771-9. PubMed ID: 17900152
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species.
Luo C; Chambers C; Yang Y; Saxena A
Chem Biol Interact; 2010 Sep; 187(1-3):185-90. PubMed ID: 20096273
[TBL] [Abstract][Full Text] [Related]
4. Y124 at the peripheral anionic site is important for the reactivation of nerve agent-inhibited acetylcholinesterase by H oximes.
Luo C; Chambers C; Pattabiraman N; Tong M; Tipparaju P; Saxena A
Biochem Pharmacol; 2010 Nov; 80(9):1427-36. PubMed ID: 20655881
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach.
Worek F; Wille T; Aurbek N; Eyer P; Thiermann H
Toxicol Appl Pharmacol; 2010 Dec; 249(3):231-7. PubMed ID: 20888357
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
8. Probing the role of amino acids in oxime-mediated reactivation of nerve agent-inhibited human acetylcholinesterase.
Chambers C; Luo C; Tong M; Yang Y; Saxena A
Toxicol In Vitro; 2015 Mar; 29(2):408-14. PubMed ID: 25451328
[TBL] [Abstract][Full Text] [Related]
9. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of interactions of paraoxon and oximes with human, Rhesus monkey, swine, rabbit, rat and guinea pig acetylcholinesterase.
Worek F; Aurbek N; Wille T; Eyer P; Thiermann H
Toxicol Lett; 2011 Jan; 200(1-2):19-23. PubMed ID: 20971170
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
Aurbek N; Thiermann H; Szinicz L; Worek F
Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
Worek F; Szinicz L; Eyer P; Thiermann H
Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.
Worek F; Thiermann H; Szinicz L; Eyer P
Biochem Pharmacol; 2004 Dec; 68(11):2237-48. PubMed ID: 15498514
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of DFP- and paraoxon-inhibited acetylcholinesterases by pyridinium oximes.
Oh KA; Park NJ; Park NS; Kuca K; Jun D; Jung YS
Chem Biol Interact; 2008 Sep; 175(1-3):365-7. PubMed ID: 18565503
[TBL] [Abstract][Full Text] [Related]
17. Estimation of oxime efficacy in nerve agent poisoning: a kinetic approach.
Worek F; Szinicz L; Thiermann H
Chem Biol Interact; 2005 Dec; 157-158():349-52. PubMed ID: 16266695
[TBL] [Abstract][Full Text] [Related]
18. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
19. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
20. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes.
Ekström FJ; Astot C; Pang YP
Clin Pharmacol Ther; 2007 Sep; 82(3):282-93. PubMed ID: 17443135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
